Abstract
Danofloxacin mesylate gelatin microspheres (DFM-GMS) were prepared by an emulsion chemical crosslinking technique. Distribution of particle size, morphologic characteristics, drug content, and drug stability were evaluated. In-vitro study showed that the release of danofloxacin mesylate (DFM) from microspheres was much slower than from the raw material (DFM) in the release medium. Pharmacokinetic characteristics were evaluated following intramuscular injection of DFM-GMS or DFM in pigs at dosage of 2.5 mg/kg body weight. Elimination half-life (t1/2β) of the drug was 24.32 h for DFM-GMS, and 6.61 h for DFM (P < 0.01). Overall, DFM-GMS could be applied as a long-acting and lung targeting dosage form of DFM for clinical application.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aliabadi, F.S. & Lees, P. (2001). Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research 62, 1979–1989.
Appelbaum, P.C. & Hunter, P.A. (2000). The fluoroquinolone antibacterials: past, present and future perspectives. International journal of antimicrobial agents 16, 5–15.
Drlica, K. & Zhao, X. (1997). DNA gyrase, topoisomerase i.v. and the 4-quinolones. Microbiology and Molecular Biology Reviews 61, 377–392.
Forni, F., Vandelli, M.A. & Cameroni, R. (1992). Influence of drug loading level on drug release and dynamic swelling of crosslinked gelatin microspheres. Journal of Microencapsulation 9, 29–39.
Friis, C. (1993). Penetration of danofloxacin into the respiratory tract tissue and secretions in calves. American Journal of Veterinary Research 54, 1122–1127.
Friis, C. & Nielsen, J.P. (1997). Penetration of danofloxacin into the respiratory tract tissues and secretions in healthy and in Actinobacillus pleuropneumoniae infected pigs. Proceedings of the 7th EAVPT Congress, Madrid, Spain. Journal of Veterinary Pharmacology and Therapeutics 20, 1108–1109.
Giles, C.J., Magonigle, R.A., Grimshaw, W.T.R., Tanner, A.C., Risk, J.E., Lynch, M.J. & Rice, J.R. (1991). Clinical pharmacokinetics of parenterally administered danofloxacin in cattle. Journal of Veterinary Pharmacology and Therapeutics 14, 400–410.
Hannan, P.C.T., Hanlon, P.J.O. & Rogers, N.M. (1989). In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens. Research in Veterinary Science 46, 202–211.
Jeyanthi, R. & Panduranga, R.K. (1987). Preparation of gelatin microspheres of bleomycin. International Journal of Pharmaceutics 35, 177–179.
Leucuta, S.E. (1986). Magnetic microspheres and microcapsules for intravenous administration of metranidozole. Drug Development and Industrial Pharmacy 12, 2281–2288.
Leucuta, S.E., Ponchel, G.. & Duchene, D. (1997). Oxprenolol release from bioadhesive gelatin: poly (acrylic acid) microspheres. Journal of Microencapsulation 14, 511–522.
Lu, B., Zhang, J.Q. & Yang, H. (2003). Lung-targeting microspheres of carboplatin. International Journal of Pharmaceutics 265, 1–11.
McKellar, Q. A., Gibson, F. I, Monteiro, A. & Bregante M. (1999). Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy 43, 1988–1992.
Morimoto, K., Katsumat, H., Yabuta, T., Iwanaga, K., Kakem, M., Tabata, Y. & Ikada, Y. (2001). Evaluation of gelatin microspheres for nasal and intramuscular administrations of salmon calcitonin. European Journal of Pharmaceutical Sciences 13, 179–185.
Neu, H.C. (1991). Synergy and antagonism of combinations with quinolones. European journal of clinical microbiology and infectious diseases 10, 255–261.
Norcia, L.J.L., Silvia, A.M. & Hayashi, S.F. (1999). Studies on time-kill kinetics of different classes of antibiotics against veterinary pathogenic bacteria including Pasteurella, Actinobacillus and Escherichia coli. Journal of Antibiotics 52, 52–60.
Shojaee, A.F. & Lees, P. (2003). Pharmacokinetic-pharmacodynamics integration of danofloxacin in the calf. Research in Veterinary Science 74, 247–259.
Shojaee, A.F., Badrelin, H., Landoni, M.F. & Lees, P. (2003a). Pharmacokinetics and PK-PD modelling of danofloxacin in camel serum and tissue cage fluids. Veterinary Journal 165, 104–118.
Shojaee, A.F., Landoni, M.F. & Lees, P. (2003b). Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy 47, 626–635.
Tabata, Y. & Ikada, Y. (1989). Synthesis of gelatin microsphere containing interferon. Pharmaceutical Research 6, 422–427.
Tabata, Y. & Ikada, Y. (1998). Protein release from gelatin matrixes. Advanced Drug Delivery Reviews 31, 287–301.
Tanaka, N., Takino, S. & Utsumi, I. (1963). A new oral gelatinized sustained-release dosage form. Journal of Pharmaceutical Sciences 52, 664–667.
Wolfson, J.S. & Hooper, D.C. (1989). Fluoroquinolone antimicrobial agents. Clinical Microbiology Reviews 2, 378–424.
Acknowledgements
The authors thank the Exquisite Farm of the Agricultural Ministry Key Laboratory of Pig Breeding and Genetics, for providing the Landrace pigs.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, C., Ai, D., Chen, C. et al. Preparation and evaluation of danofloxacin mesylate microspheres and its pharmacokinetics in pigs. Vet Res Commun 33, 1013–1022 (2009). https://doi.org/10.1007/s11259-009-9320-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11259-009-9320-6